Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BAK | CE |
|---|---|---|
| Price | $1.87 | $44.39 |
| Change today | ▲ 5.65% | ▲ 1.20% |
| Market cap | $745.17M | $4.87B |
| Return, 3 months | -25.8% | -4.8% |
| Return, year to date | -36.6% | +5.2% |
| Return, 1 year | -28.1% | +4.4% |
| P/E (TTM) | -0.7 | -4.2 |
| P/B | -0.3 | 1.2 |
| P/E percentile vs own 5y | 66th | 12th |
| Dividend yield | – | 0.27% |
| Revenue growth (YoY, latest qtr) | +21.6% | +8.7% |
| Net profit growth (YoY) | +952.1% | -35.5% |
| Gross margin | 8.9% | 20.9% |
| Operating margin | 6.0% | 8.4% |
| Net margin | -7.8% | -12.0% |
| Return on equity | – | -24.8% |
| Analyst target vs. price | -19.8% | +32.7% |
| Analyst buy share | 0% | 58% |
| RSI (14) | 52 | 43 |
| 30-day volatility | 101.0% | 41.3% |
| Max drawdown, 1 year | -71.7% | -37.7% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Sell | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
